Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Tissue Distribution. Found 23 abstracts

no pagination
Tomitaka A, Kaushik A, Kevadiya BD, Mukadam I, Gendelman HE, Khalili K, Liu G, Nair M. Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases. Drug discovery today. 2019 Mar;24(3):873-82.
Brana I, Berger R, Golan T, Haluska P, Edenfield J, Fiorica J, Stephenson J, Martin LP, Westin S, Hanjani P, Jones MB, Almhanna K, Wenham RM, Sullivan DM, Dalton WS, Gunchenko A, Cheng JD, Siu LL, Gray JE. A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours. Br J Cancer. 2014 Nov 11;111(10):1932-44.   PMCID: Pmc4229637
Doss M, Kolb HC, Walsh JC, Mocharla VP, Zhu Z, Haka M, Alpaugh RK, Chen DY, Yu JQ. Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteers. Mol Imaging Biol. 2014 Oct;16(5):739-46.
Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer. Clinical Cancer Research. 2010 Mar 15;16(6):1904-14.   PMCID: NIHMS352308
Luo W, Li J, Fourkal E, Fan J, Xu X, Chen Z, Jin L, Price R, Ma CM. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams. Phys Med Biol. 2008 Dec 21;53(24):7151-66.
Robinson MK, Shaller C, Garmestani K, Plascjak PS, Hodge KM, Yuan QA, Marks JD, Waldmann TA, Brechbiel MW, Adams GP. Effective treatment of established human breast tumor xenografts in immunodeficient mice with a single dose of the alpha-emitting radioisotope astatine-211 conjugated to anti-HER2/neu diabodies. Clin Cancer Res. 2008 Feb;14(3):875-82.   PMCID: PMC2643368
Adams GP, Shaller CC, Dadachova E, Simmons HH, Horak EM, Tesfaye A, Klein-Szanto AJ, Marks JD, Brechbiel MW, Weiner LM. A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice.[see comment]. Cancer Research. 2004 Sep;64(17):6200-6.
Engelhardt EL, Schneider RF, Seeholzer SH, Stobbe CC, Chapman JD. The synthesis and radiolabeling of 2-nitroimidazole derivatives of cyclam and their preclinical evaluation as positive markers of tumor hypoxia. J Nucl Med. 2002 Jun;43(6):837-50.
Ma J, Reed KA, Gallo JM. Cells designed to deliver anticancer drugs by apoptosis. Cancer Res. 2002 Mar;62(5):1382-7.
Prowse AH, Vanderveer L, Milling SW, Pan ZZ, Dunbrack RL, Xu XX, Godwin AK. OVCA2 is downregulated and degraded during retinoid-induced apoptosis. International journal of cancer. 2002 May 10;99(2):185-92.
Sun W, Stevenson JP, Gallo JM, Redlinger M, Haller D, Algazy K, Giantonio B, Alila H, O'Dwyer PJ. Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancer. Clin Cancer Res. 2002 Oct;8(10):3100-4.
Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res. 2001 Jun 15;61(12):4750-5.
Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene. 2001 May 16;269(1-2):131-40.
De Luca A, Tosolini A, Russo P, Severino A, Baldi A, De Luca L, Cavallotti I, Baldi F, Giordano A, Testa JR, Paggi MG. Cyclin T2a gene maps on human chromosome 2q21. J Histochem Cytochem. 2001 Jun;49(6):693-8.
Geese WJ, Raftogianis RB. Biochemical characterization and tissue distribution of human SULT2B1. Biochem Biophys Res Commun. 2001 Oct 19;288(1):280-9.
Guo P, Ma J, Li S, Guo Z, Adams AL, Gallo JM. Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model. Cancer Chemother Pharmacol. 2001 Aug;48(2):169-76.
Vulevic B, Chen Z, Boyd JT, Davis W, Walsh ES, Belinsky MG, Tew KD. Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2). Cancer Res. 2001 Apr 15;61(8):3339-47.
Salicioni AM, Xi M, Vanderveer LA, Balsara B, Testa JR, Dunbrack RL, Godwin AK. Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor. Genomics. 2000 Oct;69(1):54-62.
Tong B, Grimes HL, Yang TY, Bear SE, Qin Z, Du K, El-Deiry WS, Tsichlis PN. The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol. 1998 May;18(5):2462-73.
Wilkinson Jt, Radjendirane V, Pfeiffer GR, Jaiswal AK, Clapper ML. Disruption of c-Fos leads to increased expression of NAD(P)H:quinone oxidoreductase1 and glutathione S-transferase. Biochem Biophys Res Commun. 1998 Dec 30;253(3):855-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Tissue Distribution

Tissue Distribution metabolism US Gov't Support-PHS Non-US Gov't Support Animal Human Female Mice genetics Male pharmacokinetics Molecular Sequence Data Amino Acid Sequence drug therapy Messenger RNA pharmacology Amino Acid Sequence Homology biosynthesis pathology SCID Mice Aged administration & dosage Adult erbB-2 Receptor chemistry therapeutic use Cultured Tumor Cells Neoplasms 80 and over Aged Molecular Cloning US Gov't Support-Non-PHS Xenograft Model Antitumor Assays Complementary DNA immunology Breast Neoplasms Middle Aged Rats Drug Delivery Systems Neoplasm Antigens Ovarian Neoplasms cytology Cyclins COS Cells derivatives Kinetics Substrate Specificity Fluorescence In Situ Hybridization analogs & radiotherapy Nude Mice Radiometry Chromosome Mapping Tumor Suppressor Genes chemical synthesis isolation & purification Proteins Molecular Models Apoptosis Hela Cells Radioimmunotherapy Down-Regulation Zinc Fingers administration & Inbred ICR Mice Carbonic Anhydrases Antineoplastic Agents Proto-Oncogene Proteins c-akt Triazoles pd [Pharmacology] Antibiotics Receptor Protein-Tyrosine Kinases Proto-Oncogene Proteins Radiation Dose-Response Relationship X-Ray Computed Tomography Antioxidants antagonists & Lung Neoplasms Interleukin-6 Prasterone Spleen Hydroxysteroids Glioma Antibody Affinity Subcellular Fractions Inbred Strains Mice Nitriles Maximum Tolerated Dose Enzyme Stability im [Immunology] Astatine erbB-2) EC 2-7-1-112 (Receptor 3T3 Cells Middle Age GABA-A Receptors Gene Expression Profiling Tretinoin Cattle toxicity Skeletal Muscle Cyclin-Dependent Kinases diagnostic use aa [Analogs & Derivatives] Postmenopause Isothiocyanates 0 (Yttrium Radioisotopes) Non-US Gov't Research Support Monte Carlo Method Peptide Fragments Inbred F344 Rats Amino Acid Motifs Retinoids Phosphodiesterase Inhibitors IGF Type 1 Receptor Cell Line NADPH Oxidase Conserved Sequence Pentetic Acid Nude Rats Fenretinide Positron-Emission Tomography Isotope Labeling Dicumarol Developmental Gene Expression Regulation dosage Propionates deficiency Prostatic Neoplasms Yttrium Radioisotopes Molecular Evolution Immunoglobulin Fragments Protocols Proto-Oncogene Proteins c-fos Antibody Specificity Follow-Up Studies Randomized Controlled Trials as Topic Paclitaxel Progesterone Receptors Sprague-Dawley Rats Intensity-Modulated Radiotherapy Prospective Studies Nanoparticles Endothelial Growth Factors Lasers Treatment Outcome drug effects Cultured Cells Cell Hypoxia Stereoisomerism Protein Isoforms adverse
Last updated on Wednesday, March 04, 2020